Basilar artery diameter as neuroimaging biomarker in Chinese Fabry disease patients

被引:2
作者
Lam, Yan Lok Tiffany [1 ]
Sheng, Bun [1 ]
Kwok, Hoi Ming [2 ]
Yu, Ellen Lok Man [3 ]
Ma, Ka Fai Johnny [2 ]
机构
[1] Princess Margaret Hosp, Dept Med & Geriatr, Lai Chi Kok, 2-10 Princess Margaret Hosp Rd, Hong Kong, Peoples R China
[2] Princess Margaret Hosp, Dept Diagnost & Intervent Radiol, Lai Chi Kok, Hong Kong, Peoples R China
[3] Kowloon West Cluster, Clin Res Ctr, Kowloon, Hong Kong, Peoples R China
关键词
Fabry disease; Basilar artery; Vertebrobasilar dolichoectasia; IVS4; Chinese; DOLICHOECTASIA;
D O I
10.1186/s13023-023-02759-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BackgroundFabry disease (FD) is an X-linked lysosomal storage disease resulting from mutations of & alpha;-galactosidase A gene, and has been emphasized as one of the etiologies of young stroke and leukoencephalopathy. Vertebrobasilar dolichoectasia (VBD) is a highlighted finding in FD. We aim to examine the utility of VBD in Chinese FD by comparing the differences in basilar artery (BA) diameter of Chinese FD patients against age-matched controls with and without stroke.MethodsThis was a matched case-control study involving 37 Chinese FD patients. The BA diameters were evaluated on axial T2-weighted magnetic resonance imaging and compared to two age-and-gender matched control groups, one with stroke and one without. The association between BA diameter and stroke occurrences and white matter hyperintensities (WMH) were analyzed among all FD patients.ResultsPatients with FD had significantly increased BA diameter compared to controls with and without stroke (p < 0.001). A BA diameter of 4.16 mm could distinguish FD from controls in the stroke subgroup (ROC AUC 0.870, p = 0.001, sensitivity 80% specificity 100%), and with a cut-off of 3.21 mm in the non-stroke subgroup (ROC AUC 0.846, p < 0.001, sensitivity 77.8% specificity 88.9%). Larger BA diameter had more stroke occurrences and was moderately associated with heavier WMH load in terms of higher total FAZEKAS scores. (Spearman's rho = 0.423, p = 0.011).ConclusionVBD was also present in Chinese FD patients. BA diameter has high diagnostic utility in identifying FD from a mixed cohort of stroke and normal controls, and carried predictive value in evaluating neurological complications of FD.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Anxiety and Adverse Coronary Artery Disease Outcomes in Chinese Patients
    Wang, Gaofeng
    Cui, Jianguo
    Wang, Yanping
    Deng, Biyong
    Liang, Xiaofang
    Bai, Jianling
    Guo, Suwan
    Yang, Zhijian
    Huang, Lin
    Li, Chunjian
    [J]. PSYCHOSOMATIC MEDICINE, 2013, 75 (06): : 530 - 536
  • [32] A Case of Fabry Disease with Central Retinal Artery Occlusion
    Nakata, Daisuke
    Okada, Hiroshi
    Shimada, Yoshiaki
    Tanikawa, Atsuhiro
    Horiguchi, Masayuki
    Ito, Yasuki
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (02): : 584 - 588
  • [33] Basilar artery occlusive disease in stroke survivors in a multiethnic population
    Marchesi Ciriaco, Jovana Gobbi
    Leite, Claudia da Costa
    Morais Martin, Maria da Graca
    Barros, Cristiano Venturim
    Puglia, Paulo, Jr.
    Pereira Caldas, Jose Guilherme
    Scaff, Milberto
    Conforto, Adriana Bastos
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (03) : 233 - 236
  • [34] Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
    Frustaci, Andrea
    Verardo, Romina
    Magnocavallo, Michele
    Scialla, Rossella
    Sansone, Luigi
    Russo, Matteo Antonio
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [35] Two related Chinese Fabry disease patients with a p.N215S pathological variant who presented with nephropathy
    Sheng, Bun
    Yim, Ka Fai
    Lau, Lin Kiu
    Lee, Han Chih Hencher
    Fung, Ka Shun Samuel
    Ma, Ka Fai Johnny
    Chak, Wai Leung
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 24
  • [36] The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease
    Seyda Gul Ozcan
    Necmi Eren
    Mevlut Tamer Dincer
    Zeynep Atli
    Murat Bolayirli
    Metin Ergul
    Hakan Ozer
    Kultigin Turkmen
    Sinan Trabulus
    Nurhan Seyahi
    [J]. BMC Nephrology, 26 (1)
  • [37] MRI-visible perivascular spaces as an imaging biomarker in Fabry disease
    D. Lyndon
    I. Davagnanam
    D. Wilson
    F. Jichi
    A. Merwick
    F. Bolsover
    H. R. Jager
    L. Cipolotti
    C. Wheeler-Kingshott
    D. Hughes
    E. Murphy
    R. Lachmann
    D. J. Werring
    [J]. Journal of Neurology, 2021, 268 : 872 - 878
  • [38] MRI-visible perivascular spaces as an imaging biomarker in Fabry disease
    Lyndon, D.
    Davagnanam, I.
    Wilson, D.
    Jichi, F.
    Merwick, A.
    Bolsover, F.
    Jager, H. R.
    Cipolotti, L.
    Wheeler-Kingshott, C.
    Hughes, D.
    Murphy, E.
    Lachmann, R.
    Werring, D. J.
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (03) : 872 - 878
  • [39] Screening for Fabry disease in patients on Hemodialysis
    Batta, Gaurav
    Vishnuprasad, R.
    Batta, Anshita
    Santhanalakshmi, D.
    Dwivedi, Aradhana
    [J]. INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2024, 14 (03) : 187 - 192
  • [40] Cardiac challenges in patients with Fabry disease
    Weidemann, F.
    Linhart, A.
    Monserrat, L.
    Strotmann, J.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) : 3 - 10